Remdesivir

Jubilant Life Sciences Ltd on Monday announced that its subsidiary, Jubilant Generics,has launched remdesivir for injection, under the brand name 'JUBI-R', in the Indian market at a price of Rs 4,700 per vial of 100 mg.The company said it…

The European Commission said that it has signed a 63 million-euro contract with American pharmaceutical company Gilead to secure doses of Veklury, the brand name for Remdesivir, for the treatment of COVID-19.The Commission said in a…